Successful Treatment of Refractory Behçet's Disease with the TNF-α Blocker Infliximab
doi
10.22034/iji.2009.17074
کلیدواژهها
Ahmad Jalili1,
Tamar Kinaciyan1,
Talin Barisani2,
Markus Peck-Radosavljevic3,
Georg Stingle1,
Alexandra Geusau1,
Stefan Wöhrl1,
Behcet’s Disease,
Infliximab,
TNF-alpha,
Hepatitis B
